Experimental ALS drug OK'd by Health Canada
Health Canada has approved an experimental drug for amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease, as uncertainty persists about the drug's clinical benefit.
National drug shortage triggers some heart testing delays in Alberta doctors say
A countrywide shortage of drug used for heart imaging is sparking testing delays for some Alberta cardiology patients.
Comments
Post a Comment